血清素4受体亚型:特别感兴趣的目标,特别是对于大脑疾病
1Institut des Sciences Cognitives Marc Jeannerod (ISCMJ), Unité Mixte de Recherche 5229 du Centre National de la Recherche Scientifique (CNRS), 69675 Bron, France.
International journal of molecular sciences
|May 25, 2024
概括
血清素4受体 (5-HT4) 在大脑和身体中发现,影响情绪,认知和食欲. 它的调制提供了快速的抗抑郁作用和治疗各种疾病的潜力.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 胃肠病学 胃肠病学
背景情况:
- 血清素4受体 (5-HT4) 在大脑和外周器官中分布广泛.
- 它由各种神经元类型表达,包括GABAergic,glutamatergic和胆固醇神经元.
- 该受体的广泛表达表明它参与了许多生理功能.
研究的目的:
- 审查血清素4受体的多方面的作用和治疗潜力.
- 要突出受体在神经,认知和胃肠功能中的参与.
- 讨论5-HT4受体调节在治疗各种疾病中的优势.
主要方法:
- 关于血清素4受体分布和功能研究的文献综述.
- 对5-HT4受体调节效应的研究分析.
- 检查临床应用和治疗潜力.
主要成果:
- 血清素4受体在基本,皮质,海马体和杏仁体等大脑区域以及胃肠道中高度表达.
- 5-HT4受体的调节会影响神经递质的释放,包括血清素,乙胆和多巴胺.
- 5-HT4受体的激活显示出快速的抗抑郁和抗焦虑作用,增强认知表现,并调节食物摄入.
- 5-HT4受体激动剂在治疗胃肠道疾病方面非常有价值.
结论:
- 血清素4受体是治疗各种疾病的有希望的点.
- 它的快速作用和对神经传递的广泛影响为传统治疗提供了显著的优势.
- 需要进一步的研究,以充分阐明它在运动障碍中的作用.
相关概念视频
Antidepressant Drugs: MAOIs and Other Agents
225
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
225
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
248
Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...
248
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
580
Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
580
G-protein Coupled Receptors
118.3K
G-protein coupled receptors are ligand binding receptors that indirectly affect changes in the cell. The actual receptor is a single polypeptide that transverses the cell membrane seven times creating intracellular and extracellular loops. The extracellular loops create a ligand specific pocket which binds to neurotransmitters or hormones. The intracellular loops holds onto the G-protein.
118.3K
Drugs Affecting Neurotransmitter Release or Uptake
1.0K
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
1.0K
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
370
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
370


